BETMIGA

This brand name is authorized in Austria, Croatia, Cyprus, Estonia, Finland, France, Germany, Hong Kong SAR China, Ireland, Israel, Lithuania, Netherlands, Poland, Romania, Singapore, South Africa, Spain, Turkey, UK.

Active ingredients

The drug BETMIGA contains one active pharmaceutical ingredient (API):

1	Mirabegron UNII MVR3JL3B2V - MIRABEGRON
	Mirabegron is a potent and selective beta3-adrenoceptor agonist. Mirabegron enhances urine storage function by stimulating beta3-adrenoceptors in the bladder.
	Read more about Mirabegron

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
BETMIGA Prolonged-release tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G04BD12		G Genito urinary system and sex hormones → G04 Urologicals → G04B Other urologicals, incl. antispasmodics → G04BD Urinary antispasmodics
Discover more medicines within G04BD12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	11676019, 11676031
EE	Ravimiamet	1604179, 1604269, 1604270, 1604281, 1604292, 1604304, 1604315, 1604326, 1604337, 1604348, 1604359, 1604360, 1645286, 1645297, 1645309, 1645310
ES	Centro de información online de medicamentos de la AEMPS	112809010
FI	Lääkealan turvallisuus- ja kehittämiskeskus	093284, 409927, 501278, 595198
FR	Base de données publique des médicaments	61782473, 66383994
GB	Medicines & Healthcare Products Regulatory Agency	219732, 219735, 379799, 379801, 381198
HK	Department of Health Drug Office	62460, 62461
IE	Health Products Regulatory Authority	17598, 17632, 17633
IL	מִשְׂרַד הַבְּרִיאוּת	7534, 7535
LT	Valstybinė vaistų kontrolės tarnyba	1069203, 1069204, 1069205, 1069206, 1069207, 1069208, 1069209, 1069210, 1069211, 1069212, 1069213, 1069214, 1069215, 1069216, 1072975, 1072976, 1072977, 1072978
NL	Z-Index G-Standaard, PRK	112305
PL	Rejestru Produktów Leczniczych	100295334, 100295357
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W59965001, W59965002, W59965003, W59965004, W59965005, W59965006, W59965007, W59966001, W59966002, W59966003, W59966004, W59966005, W59966006, W59966007
SG	Health Sciences Authority	14622P, 14623P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699043890024, 8699043890031, 8699043890055, 8699043890062, 8699043890079, 8699043890086, 8699043890093, 8699043890109, 8699043890116, 8699043890123, 8699043890130, 8699043890147, 8699043890154, 8699043890161
ZA	Health Products Regulatory Authority	47/16.5/0297, 47/16.5/0298